We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Northwest Biotherapeutics Inc (QB) | USOTC:NWBO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.00594 | -1.27% | 0.46 | 0.451 | 0.4699 | 0.48 | 0.458 | 0.465 | 1,273,919 | 21:30:14 |
October 14, 2021 -- InvestorsHub NewsWire -- via pennymillions --
iQSTEL, Inc. (OTCQX: IQST) is on track to meet a $60.5 million annual revenue forecast. The upcoming Q3 report could be a trigger to catapult the stock from its plus or minus $0.50 price back to its well deserved $2.00 52 week high delivering a 4X ROI.
The company has been growing its topline quarter-to-quarter and the upcoming Q3 financial report is likely to show another quarter-to-quarter revenue expansion in addition to a further validation of the $60.5 million annual revenue forecast being in reach.
Perfect Storm – EV Market Entry, Q3 Financials and Short Squeeze
IQST is on the verge of making its Electric Vehicle (EV) market debut with the delivery of its first batch of electric motorcycles into South America.
IQST – iQSTEL Releases Sneak Peek Of EVOSS Electric Motorcycle Deploying Soon (Video)
As crazy as it sounds with consistent quarter-to-quarter growth and the impending Q3 report on the horizon combined with the imminent entry into the red-hot EV market, someone is hedging against IQST’s ongoing performance. Recent trading has seen consistent short selling with nearly half of the daily volume being reported by FINRA as short sales.
A consistent Q3 report + EV Entry + Short Squeeze = A Potential Rally Back To $2.00
Source - https://www.pennymillions.com/blog/jvo1l3avbnicptdciuc3yoad8ptxqv
Other stocks on the move include AMBL, ALPP and NWBO.
SOURCE: pennymillions
1 Year Northwest Biotherapeutics (QB) Chart |
1 Month Northwest Biotherapeutics (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions